Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2008 032 398.6 |
96 | EP file number | EAKZ | 08 73 2818.3 |
86 | WO file number | WAKZ | PCT/US2008/058183 |
97 | EP publication number | EPN | 2203462 |
87 | WO publication number | WPN | 2008121634 |
54 | Designation/title | TI | NUKLEOSID-PHOSPHORAMIDAT-PRODRUGS |
51 | IPC main class | ICM (ICMV) | A61K 31/7072 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/7076 (2006.01), A61K 31/7064 (2006.01) |
22 | DE application date | DAT | Mar 26, 2008 |
96 | EP application date | EAT | Mar 26, 2008 |
86 | WO application date | WAT | Mar 26, 2008 |
43 | Date of first publication | OT | Oct 9, 2008 |
| Date of publication of grant | PET | May 21, 2014 |
71/73 | Applicant/owner | INH | Gilead Pharmasset LLC, Foster City, Calif., US |
72 | Inventor | IN | SOFIA, Michael, Joseph, Doylestown, PA 18902, US; NAGARATHNAM, Dhanapalan, Bethany, CT 06524, US; WANG, Peiyuan, Glen Rock, NJ 07452, US; DU, Jinfa, New Hope, PA 18938, US |
74 | Representative | VTR | Marks & Clerk (Luxembourg) LLP, Luxembourg, LU |
| Address for service | | Marks & Clerk (Luxembourg) LLP, 1017 LUXEMBURG, LU |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 982309 P Oct 24, 2007
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 909315 P Mar 30, 2007
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 53015 Mar 21, 2008
|
| Due date | FT FG | Mar 31, 2026 Annual fee for the 19th year
Patent fees |
| Patent division in charge | | 44 |
21 | File number of protection certificate | ZAKZ | 12 2014 000 108.1 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002203462 Searchable text:
EP000002203462 Original document:
EP000002203462B1 Searchable text:
EP000002203462B1 Original document:
EP000002203462B2 Searchable text:
EP000002203462B2 Original document:
WO002008121634 Searchable text:
WO002008121634 |
43 | Date of first publication | EVT | Oct 9, 2008 |
| Date of the first transfer into DPMAregister | EREGT | May 26, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 15, 2025 (Show all update days)(Hide all update days)- Jan 15, 2025
- Oct 10, 2024
- Procedures: Opposition procedure, Decision by EPO to maintain patent in amended form has become final, 25.09.2024: changed
- Sep 5, 2024
- Published EP/WO documents: changed
- Procedures: Opposition procedure, Decision by EPO to maintain patent in amended form has become final, 25.09.2024: new
- Procedures: Opposition procedure, Patent maintained in amended form by EPO, 25.09.2024: new
- Jan 17, 2024; Feb 8, 2023; Feb 10, 2022; Mar 20, 2021; Apr 2, 2020; Aug 13, 2019; Apr 9, 2019; Oct 29, 2018; Apr 12, 2018; Aug 31, 2017; Jul 22, 2017; Apr 12, 2017; Apr 8, 2017; Feb 9, 2017; Sep 22, 2016; Apr 15, 2016; Apr 8, 2016; Apr 10, 2015; Apr 7, 2015; Mar 19, 2015; Nov 26, 2014; Jul 25, 2014; Jul 23, 2014; Jul 22, 2014; Jul 18, 2014; Jul 3, 2014; Jun 26, 2014; May 27, 2014; May 22, 2014; Feb 14, 2013
- Historical data not available for this/these date(s)
- May 26, 2011
- Date of the first transfer into DPMAregister
|